NO975330L - Fremgangsmåte for ökning av blodströmshastigheten i retona og optisk nervehode for å bevare synet - Google Patents

Fremgangsmåte for ökning av blodströmshastigheten i retona og optisk nervehode for å bevare synet

Info

Publication number
NO975330L
NO975330L NO975330A NO975330A NO975330L NO 975330 L NO975330 L NO 975330L NO 975330 A NO975330 A NO 975330A NO 975330 A NO975330 A NO 975330A NO 975330 L NO975330 L NO 975330L
Authority
NO
Norway
Prior art keywords
retona
procedures
flow rate
blood flow
optic nerve
Prior art date
Application number
NO975330A
Other languages
English (en)
Other versions
NO318600B1 (no
NO975330D0 (no
Inventor
William Eric Sponsen
Alon Harris
Original Assignee
Merck & Co Inc
Indiana University Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc, Indiana University Foundation filed Critical Merck & Co Inc
Publication of NO975330D0 publication Critical patent/NO975330D0/no
Publication of NO975330L publication Critical patent/NO975330L/no
Publication of NO318600B1 publication Critical patent/NO318600B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433Thidiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/382Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO19975330A 1995-05-22 1997-11-20 Anvendelse av en karboanhydraseinhibitor for okning av blodstromshastigheten i retina og optisk nervehode for a bevare synet NO318600B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/445,839 US5789435A (en) 1995-05-22 1995-05-22 Method to increase retinal and optical nerve head blood flow velocity in order to preserve sight
PCT/US1996/007225 WO1996037203A1 (en) 1995-05-22 1996-05-17 Method to increase retinal blood flow

Publications (3)

Publication Number Publication Date
NO975330D0 NO975330D0 (no) 1997-11-20
NO975330L true NO975330L (no) 1998-01-07
NO318600B1 NO318600B1 (no) 2005-04-18

Family

ID=23770397

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19975330A NO318600B1 (no) 1995-05-22 1997-11-20 Anvendelse av en karboanhydraseinhibitor for okning av blodstromshastigheten i retina og optisk nervehode for a bevare synet

Country Status (20)

Country Link
US (1) US5789435A (no)
EP (1) EP0833632A1 (no)
JP (1) JPH11503462A (no)
KR (1) KR19990021853A (no)
CN (1) CN1186019C (no)
AU (1) AU703301B2 (no)
BG (1) BG63148B1 (no)
BR (1) BR9609297A (no)
CA (1) CA2218549C (no)
CZ (1) CZ289224B6 (no)
EE (1) EE9700361A (no)
HU (1) HUP9802553A3 (no)
IS (1) IS4611A (no)
NO (1) NO318600B1 (no)
NZ (1) NZ308016A (no)
RU (1) RU2181045C2 (no)
SK (1) SK283960B6 (no)
TR (1) TR199701406T1 (no)
UA (1) UA48178C2 (no)
WO (1) WO1996037203A1 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002506461A (ja) * 1997-06-26 2002-02-26 メルク エンド カンパニー インコーポレーテッド 網膜及び視神経の健康の最適化方法
US6126037A (en) * 1997-09-09 2000-10-03 Merck & Co., Inc. Flow control orifice
WO1999030717A1 (en) * 1997-12-12 1999-06-24 Alcon Laboratories, Inc. Use of brinzolamide for the manufacture of a medicament for improving ocular blood flow
ATE311880T1 (de) * 1998-01-23 2005-12-15 Einar Stefansson Carbonische anhydrase inhibitor zur steigerung des sauerstoffdrucks im sehnerv und retina
WO1999044603A1 (en) * 1998-03-06 1999-09-10 Sponsel William E Composition and method for treating macular disorders
WO2004073708A1 (en) 1998-12-17 2004-09-02 Dean Thomas R Brinzolamide and brimonidine for treating ocular conditions
JP4717996B2 (ja) * 2000-10-11 2011-07-06 サーパス工業株式会社 容器及びそれに用いるプラグ
US20040046934A1 (en) * 2002-02-14 2004-03-11 Board Of Regents, The University Of Texas System Oculokinetic offset acuity testing
RU2232582C2 (ru) * 2002-07-29 2004-07-20 Уфимский научно-исследовательский институт глазных болезней Глазная пленка
US20040242457A1 (en) * 2003-05-27 2004-12-02 Ashby Charles R. Use of anti-glaucoma drugs to treat visual defects associated with the use of a GABAergic agent
GB2413282B (en) * 2004-04-23 2009-01-14 Henderson Morley Plc DNA Viral Infections
US20060073172A1 (en) * 2004-10-01 2006-04-06 Schneider L W Stabilized ophthalmic solution for the treatment of glaucoma and lowering intraocular pressure
MX2007011165A (es) * 2007-09-12 2009-03-11 Arturo Jimenez Bayardo Composición farmacéutica estable de timolol, dorzolamida y brimonidina.
US10363245B2 (en) 2017-02-22 2019-07-30 The Board Of Regents Of The University Of Texas System Methods for treating CNS lesions
MX2020005761A (es) 2017-12-03 2020-08-20 Natureworks Llc Composiciones de resinas polilacticas para recubrimiento de carton y procesos de recubrimiento de carton con uso de las composiciones.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4416890A (en) * 1981-07-13 1983-11-22 Merck & Co., Inc. Benzothiazolesulfonamide derivatives for the topical treatment of elevated intraocular pressure
US4386098A (en) * 1981-11-03 1983-05-31 Merck & Co., Inc. 6-Hydroxy-2-benzothiazolesulfonamide for the topical treatment of elevated intraocular pressure
US4426388A (en) * 1982-04-02 1984-01-17 Merck & Co., Inc. 5-Benzothiazolesulfonamide derivatives for the topical treatment of elevated intraocular pressure
US4797413A (en) * 1986-05-14 1989-01-10 Merck & Co., Inc. Thieno thiopyran sulfonamide derivatives, pharmaceutical compositions and use
US5138069A (en) * 1986-07-11 1992-08-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
GB2203039B (en) * 1987-03-02 1990-10-24 American Cyanamid Co Stable ophthalmic preparations containing acetazolamide
US5494901A (en) * 1993-01-05 1996-02-27 Javitt; Jonathan C. Topical compositions for the eye comprising a β-cyclodextrin derivative and a therapeutic agent

Also Published As

Publication number Publication date
SK153597A3 (en) 1998-07-08
EP0833632A1 (en) 1998-04-08
JPH11503462A (ja) 1999-03-26
CN1199336A (zh) 1998-11-18
AU5754096A (en) 1996-12-11
TR199701406T1 (xx) 1998-03-21
CN1186019C (zh) 2005-01-26
WO1996037203A1 (en) 1996-11-28
CA2218549C (en) 2005-09-20
RU2181045C2 (ru) 2002-04-10
NO318600B1 (no) 2005-04-18
MX9709063A (es) 1998-10-31
BR9609297A (pt) 1999-08-17
SK283960B6 (sk) 2004-06-08
US5789435A (en) 1998-08-04
AU703301B2 (en) 1999-03-25
EE9700361A (et) 1998-06-15
HK1020166A1 (en) 2000-03-31
KR19990021853A (ko) 1999-03-25
CZ369497A3 (cs) 1998-06-17
BG102064A (en) 1998-07-31
CA2218549A1 (en) 1996-11-28
EP0833632A4 (no) 1998-05-20
NO975330D0 (no) 1997-11-20
IS4611A (is) 1997-11-10
HUP9802553A2 (hu) 1999-04-28
NZ308016A (en) 2000-09-29
BG63148B1 (bg) 2001-05-31
UA48178C2 (uk) 2002-08-15
HUP9802553A3 (en) 2002-01-28
CZ289224B6 (cs) 2001-12-12

Similar Documents

Publication Publication Date Title
NO975330L (no) Fremgangsmåte for ökning av blodströmshastigheten i retona og optisk nervehode for å bevare synet
IT1219405B (it) Procedimento e dispositivo per la visione strumentale in condizioni di scarsa visibilita in particolare per la guida nella nebbia
EP0778033A3 (de) Vorrichtung zur Behandlung von Blut mit Flüssigkeitsbilanzierung
ATE301473T1 (de) Verbesserung des sehens durch photodynamische therapie des auges
AU3689595A (en) Device for use in the laser treatment of biological tissue (variants thereof)
AU8072294A (en) Improved visualization of choroidal blood flow and aberrant vascular structures in the eye
AU7960587A (en) Headband and eyeglasses combination
AU1757695A (en) Transparent liquid dentifrice
TR199600499A2 (tr) S(+)-Etodolak'in oral formülasyonlari.
ITBO930059A0 (it) Procedimento per ottenere la rigenerazione dei tessuti nella terapia odontoiatrica parodentale.
AU7691698A (en) Examining the optic nerve head blood circulation
GB9318853D0 (en) Improvements in relation to medical diathermy
FI960301L (fi) Nikkelitön hemoglobiini ja menetelmät sellaisen hemoglobiinin tuottamiseksi
NZ291053A (en) Method to maximise the health of the optic nerve and retina by using a beta-adrenergic blocking agent
AU7011098A (en) Treatment of adverse effects associated with administration of extracellular hemoglobin
AU3657195A (en) Device for measuring simultaneously the tissue blood flow rate and the extra-cellular liquid composition
FR2718254B1 (fr) Lunettes, notamment de vue ou solaires, et monture s'y rapportant.
RU95111665A (ru) Способ фиксации составного мостовидного протеза
KR960013366U (ko) 의료용 헤드미러
ITMI940214A0 (it) Dispositivo perfezionato per attuare l'auto-insufflazione nel trattamento dell'otite media
ZA9610264B (en) Preparation for use in the treatment of skin disorders.
IT8821538V0 (it) Caricatore di spine per l'unione di elementi di telaio di serramenti e simili.
KR950034208U (ko) 브이씨알의 테이크 업 포스트 구동장치
IT1275944B1 (it) Dispositivo per migliorare la confortevolezza dello sciatore e la dinamicita' di sciata
KR970029496U (ko) 자동차의 이중 선바이저

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees